Showing results (181-190 of 228) with videos related to

Sort By:
Pageof 23
Plos One|April 6, 2012
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinomaChad J Creighton, Anadulce Hernandez-Herrera, Anders Jacobsen, et al.
BMC Medical Genomics|February 21, 2009
High quality copy number and genotype data from FFPE samples using Molecular Inversion Probe (MIP) microarraysYuker Wang, Victoria E H Carlton, George Karlin-Neumann, et al.
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
Tuberculosis (Edinburgh, Scotland)|May 22, 2010
TB database 2010: overview and updateJames E Galagan, Peter Sisk, Christian Stolte, et al.
Nucleic Acids Research|October 7, 2008
TB database: an integrated platform for tuberculosis researchT B K Reddy, Robert Riley, Farrell Wymore, et al.
Plos One|July 17, 2015
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura Heiser, et al.
The Journal of Clinical Investigation|February 1, 2024
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trialZheqi Li, Otto Metzger Filho, Giuseppe Viale, et al.
Cancer Cell|December 13, 2006
Genomic and transcriptional aberrations linked to breast cancer pathophysiologiesKoei Chin, Sandy DeVries, Jane Fridlyand, et al.
Plos One|October 12, 2017
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E Korkola, Eric A Collisson, Laura M Heiser, et al.
JCI Insight|April 22, 2021
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancerMichalina Janiszewska, Shayna Stein, Otto Metzger Filho, et al.
Pageof 23